PURPOSE
The present study evaluated the pharmacological interaction of temozolomide (TMZ) chemotherapy with 3 potential antidepressant treatments (cannabidiol, CBD; fluoxetine, FLX; metformin, MET) in a rat glioblastoma model with the objective of finding drug combinations to better treat the depressive symptoms observ...
Laura Gálvez-Melero, Julia Bihorac, M. Hadamitzky et al.· Neuroscience· 0 citations
Temozolomide (TMZ), the gold standard drug used for the treatment of glioblastoma, is known to affect healthy brain proliferating cells, inhibiting adult hippocampal neurogenesis. Since most antidepressants mediate their beneficial effect through this process and given the large proportion of glioblastoma patients with...
Laura Gálvez-Melero, Edurne Mugica-Urruzola, E. Tovar-Ambel et al.· Neuroscience· 0 citations
Temozolomide induced signs of antidepressant-like responses as measured in the forced-swim test in a treatment-duration manner and decreased NeuroD and hippocampal FADD, a neuroplastic marker previously associated with the acute and repeated actions of most antidepressants.
Laura Gálvez-Melero, M. García-Fuster· Pharmacological Reports· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.